# High-Resolution Genomic Risk Stratification for Sickle Cell Disease in Nigeria

## 1. Problem Statement

Nigeria carries the highest burden of Sickle Cell Disease (SCD) globally, with approximately **150,000 babies born with the condition annually**. While basic genotype testing (AA, AS, SS) exists, it fails to account for clinical heterogeneity, the phenomenon where two individuals with the same SS genotype experience vastly different survival rates and pain frequencies.

The current manual workaround involves **reactive crisis management** rather than **proactive prevention**. Most diagnostic frameworks are built on European genetic markers, which often miss critical African-specific genetic modifiers like the:
- BCL11A variants
- HBS1L-MYB variants

These significantly influence fetal hemoglobin (HbF) levels and disease severity in Nigerian cohorts. 

Furthermore, a massive **digital divide** prevents uneducated or rural populations from accessing genetic counseling, while existing hospital systems operate in silos without integrated molecular diagnostic support.

## 2. Proposed Solution: The `Naija-Gen` Intelligence Layer

I propose a **localized platform** that moves beyond simple diagnosis to **Precision Risk Stratification**. This system integrates African-specific genomic data with clinical variables to predict disease complications before they occur.

### A. Core Mechanism and Feasibility

- **Target Variable**: Prediction of a Clinical Severity Score (High, Medium, or Low risk of stroke or organ damage)
- **Learning Paradigm**: Supervised Learning using Tree-Based models ( e.g Random Forest or XGBOOST) for tabular genomic and clinical data, and Language based models/Vision models for processing unstructured physician notes
- **Data Sources**: Utilizing the 1000 Genomes Project (YRI population) and H3Africa datasets to ensure the model is trained on indigenous genetic architecture
- **Human-in-the-Loop**: Reports are validated by hematologists before being sent to patients to ensure ethical compliance

### B. Accessibility and Integration Features

To bridge the literacy gap and ensure the solution provides real-world utility, the platform includes:

- **Linguistic Inclusion**: Integration of Speech-to-Text (STT) and Text-to-Speech (TTS) in local dialects (Yoruba, Hausa, Igbo) and Pidgin, allowing uneducated users to query their health status via voice. As of today, we have the N-ATLaS model that provides 4 Automatic speech recognition models which is open-source. Also, we have Yarn-GPT api that can accurately generate audios from texts.
- 
- **Multichannel Notification**: Free automated email alerts for routine checkups and a premium WhatsApp API integration for real-time crisis support and laboratory results
- 
- **Clinic-as-a-Platform (CaaP)**: An API-first design that allows existing Nigerian Electronic Medical Record (EMR) systems in hospitals like Federal Medical Centre (FMC) Jabi and National Hospital Abuja  plug in and receive genomic analysis without overhauling their current software

## 3. Implementation Research and Technical Feasibility

My proposed solution indicates that the lift from this intelligence is justifiable because current diagnostic methods in Nigeria lack predictive power for Hydroxyurea response (the positive, measurable changes in a patient's blood profile and clinical condition after taking hydroxyurea - a medication used for sickle cell diseases, blood cancerws and other disorders). 
By focusing on **Pharmacogenomics**, The model can predict which patients will benefit most from specific treatments, saving families significant costs on ineffective medications.

### Stakeholder Mapping

- **Primary Users**: Rural and urban SCD patients, nursing mothers, and hematologists
- **Data Gatekeepers**: Nigerian Institute of Medical Research (NIMR), private diagnostic labs, and the Federal Ministry of Health
- **Sponsors**: National Health Insurance Authority (NHIA) and international NGOs focused on maternal and child health

## 4. Success Metrics

To evaluate the viability and real-world impact of this intervention, we will track:

### Technical Metrics
- **F1-Score (>0.85)**: Balancing precision and recall in identifying high-risk silent stroke candidates
- **Latency**: Ensuring the TTS/STT engine processes local dialects in under 2 seconds for seamless user interaction

### Impact Metrics
- **Clinical Efficacy**: 20% reduction in emergency hospitalizations for pain crises among the pilot user group
- **Accessibility**: Percentage of users successfully interacting with the system via voice vs. text (Target: 40% voice-based)
- **Integration**: Number of private and public clinics successfully utilizing the API for patient data analysis

## 5. Why This Solution is Unique
it is **African-Centric by Design**:

- **Genomic Sovereignty**: It prioritizes the African genome, which contains more genetic diversity than the rest of the world combined
- **Infrastructure Resilience**: The core processing logic is designed to handle batch processing on low-bandwidth connections, with a lite version of the model capable of running offline on local clinic servers
- **Low Friction**: By meeting users where they are (WhatsApp and Voice), the technical barriers that typically hinder adoption in low-resource settings is removed.